CD47 and cancer: CD47 molecule, a ubiquitous cell-surface receptor that promotes immune evasion by interacting with signal-regulatory protein alpha (SIRPα) [1], is a member of immunoglobulin (Ig) superfamily and is considered as a promising cancer biomarker [2].